MERGING TRAFFIC — Full Portfolio
3 tracked investments · listed companies and verified rows first
Continuity Biosciences develops adaptive precision drug-delivery platforms that combine engineering and biology to help therapies reach their intended targets more effectively.
BiotechDeep TechMedical DevicesBradenton, US
Ramakrishna Venugopalan(Co-Founder & Chief Executive Officer)Robert Whitehead(Co-Founder & Executive Chair)
BoardAlessandro Grattoni(Chief Scientific Advisor)
Board seatAllen R. Weiss· per SEC Form D · $12M raise · filed Aug 2025
Intecrowd is a boutique Workday services partner offering deployment, integration, application management, and reporting/analytics support across HR and finance systems.
Enterprise SoftwareHR TechSaaSOrlando, US
DONALD D MCDOUGAL(Manager and Chief Executive Officer)JOSEPH G WALKER(Chief Operating Officer)
BoardDAVID METCALF(Chairman)
Board seatDavid S Metcalf· per SEC Form D · $1.9M raise · filed Feb 2017
Co-investorsFlorida FundersFlorida Technology Seed Capital Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
MERGING TRAFFIC, INC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

